| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.272 | 1.313 | 1.790 | 1.860 | 1.032 | 2.221 | 2.261 | 1.451 | 712 | 1.870 |
| Total Income - EUR | 2.272 | 1.313 | 1.790 | 1.860 | 1.032 | 2.221 | 2.261 | 1.451 | 712 | 1.870 |
| Total Expenses - EUR | 574 | 188 | 227 | 236 | 956 | 657 | 146 | 926 | 577 | 1.321 |
| Gross Profit/Loss - EUR | 1.697 | 1.125 | 1.562 | 1.624 | 76 | 1.564 | 2.115 | 524 | 135 | 548 |
| Net Profit/Loss - EUR | 1.629 | 1.086 | 1.509 | 1.568 | 45 | 1.498 | 2.047 | 481 | 113 | 395 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Raphael Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 604 | 442 | 294 | 138 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.314 | 1.439 | 1.181 | 2.933 | 2.964 | 4.472 | 6.488 | 6.993 | 7.090 | 7.639 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18 | 18 | 18 | 17 | 17 | 17 | 16 | 16 | 0 | 0 |
| Cash | 1.296 | 1.421 | 1.163 | 2.916 | 2.947 | 4.456 | 6.472 | 6.976 | 7.090 | 7.639 |
| Shareholders Funds | -1.319 | -220 | 1.292 | 2.837 | 2.827 | 4.271 | 6.224 | 6.725 | 6.818 | 7.175 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.237 | 2.101 | 182 | 234 | 137 | 201 | 264 | 268 | 273 | 465 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Raphael Medica S.r.l.